BIOMAT Database Logo BIOMAT Database Logo

[CB-154 in the treatment of acromegaly]. 1977

K Hanio, and M Aida, and A Sasaki, and Yoshinaga

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Treatment of acromegaly using CB-154].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Treatment of acromegaly with CB-154].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[CB-154 in the treatment of acromegaly: conclusion].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[CB-154 in the treatment of acromegaly: Introduction].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Treatment of acromegaly with bromocriptine (CB 154)].
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[CB-154 therapy in acromegaly].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Effect of CB-154 in the treatment of acromegaly].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Effect of CB-154 in acromegaly].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Clinical results in the treatment of acromegaly with CB-154].
December 1977, Horumon to rinsho. Clinical endocrinology,
K Hanio, and M Aida, and A Sasaki, and Yoshinaga
[Effect of CB-154 on acromegaly].
December 1977, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!